About inogen inc - INGN
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
INGN At a Glance
Inogen, Inc.
859 Ward Drive
Goleta, California 93111
| Phone | 1-805-562-0500 | Revenue | 335.71M | |
| Industry | Medical Specialties | Net Income | -35,888,000.00 | |
| Sector | Health Technology | 2024 Sales Growth | 6.35% | |
| Fiscal Year-end | 12 / 2025 | Employees | 766 | |
| View SEC Filings |
INGN Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.646 |
| Price to Book Ratio | 1.261 |
| Price to Cash Flow Ratio | 36.68 |
| Enterprise Value to EBITDA | -6.707 |
| Enterprise Value to Sales | 0.354 |
| Total Debt to Enterprise Value | 0.163 |
INGN Efficiency
| Revenue/Employee | 438,257.18 |
| Income Per Employee | -46,851.175 |
| Receivables Turnover | 11.153 |
| Total Asset Turnover | 1.079 |
INGN Liquidity
| Current Ratio | 2.418 |
| Quick Ratio | 2.095 |
| Cash Ratio | 1.531 |
INGN Profitability
| Gross Margin | 48.402 |
| Operating Margin | -11.538 |
| Pretax Margin | -10.865 |
| Net Margin | -10.69 |
| Return on Assets | -11.533 |
| Return on Equity | -18.955 |
| Return on Total Capital | -18.569 |
| Return on Invested Capital | -17.357 |
INGN Capital Structure
| Total Debt to Total Equity | 11.162 |
| Total Debt to Total Capital | 10.041 |
| Total Debt to Total Assets | 6.552 |
| Long-Term Debt to Equity | 9.544 |
| Long-Term Debt to Total Capital | 8.586 |